Mirum Pharmaceuticals, Inc.
US ˙ NasdaqGM ˙ US6047491013

SecurityMIRM / Mirum Pharmaceuticals, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership1,052,048 shares
Latest Disclosed Value $ 97,188,194
Citadel Advisors Llc ownership in MIRM / Mirum Pharmaceuticals, Inc.

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 1,052,048 shares of Mirum Pharmaceuticals, Inc. (US:MIRM) valued at $97,188,194 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 840,220 shares of Mirum Pharmaceuticals, Inc.. This represents a change in shares of 25.21% during the quarter. The current value of the position is $98,345,447 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (MIRM) in the form of stock options. The firm currently holds call options representing 11,500 of underlying shares valued at $1,062,370 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MIRM / Mirum Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F MIRUM PHARMACEUTICALS COM 604749101 1,052,048 211,828 25.21 97,188 46.44 0.0138
2026-02-17 2025-12-31 13F MIRUM PHARMACEUTICALS COM 604749101 840,220 -200,324 -19.25 66,369 -13.00 0.0100
2025-11-14 2025-09-30 13F MIRUM PHARMACEUTICALS COM 604749101 1,040,544 -365,808 -26.01 76,282 6.59 0.0116
2025-08-14 2025-06-30 13F MIRUM PHARMACEUTICALS COM 604749101 1,406,352 -39,643 -2.74 71,569 9.87 0.0124
2025-05-15 2025-03-31 13F MIRUM PHARMACEUTICALS COM 604749101 1,445,995 -65,188 -4.31 65,142 4.25 0.0124
2025-02-14 2024-12-31 13F MIRUM PHARMACEUTICALS COM 604749101 1,511,183 119,774 8.61 62,487 15.15 0.0108
2024-11-14 2024-09-30 13F MIRUM PHARMACEUTICALS COM 604749101 1,391,409 -194,215 -12.25 54,265 0.10 0.0105
2024-08-14 2024-06-30 13F MIRUM PHARMACEUTICALS COM 604749101 1,585,624 193,118 13.87 54,212 54.98 0.0110
2024-05-15 2024-03-31 13F MIRUM PHARMACEUTICALS COM 604749101 1,392,506 -50,306 -3.49 34,980 -17.87 0.0067
2024-02-14 2023-12-31 13F MIRUM PHARMACEUTICALS COM 604749101 1,442,812 -274,445 -15.98 42,592 -20.63 0.0085
2023-11-14 2023-09-30 13F MIRUM PHARMACEUTICALS COM 604749101 1,717,257 287,412 20.10 53,663 45.07 0.0115
2023-08-14 2023-06-30 13F MIRUM PHARMACEUTICALS COM 604749101 1,429,845 60,500 4.42 36,990 12.46 0.0076
2023-05-15 2023-03-31 13F MIRUM PHARMACEUTICALS COM 604749101 1,369,345 -39,214 -2.78 32,892 19.75 0.0072
2023-02-14 2022-12-31 13F MIRUM PHARMACEUTICALS COM 604749101 1,408,559 483,382 52.25 27,467 41.30 0.0064
2022-11-14 2022-09-30 13F MIRUM PHARMACEUTICALS COM 604749101 925,177 495,330 115.23 19,438 132.37 0.0044
2022-08-15 2022-06-30 13F MIRUM PHARMACEUTICALS COM 604749101 429,847 96,819 29.07 8,365 14.07 0.0021
2022-05-16 2022-03-31 13F MIRUM PHARMACEUTICALS COM 604749101 333,028 206,602 163.42 7,333 263.56 0.0015
2022-02-14 2021-12-31 13F MIRUM PHARMACEUTICALS COM 604749101 126,426 39,948 46.19 2,017 17.06 0.0004
2021-11-15 2021-09-30 13F MIRUM PHARMACEUTICALS Cmn 604749101 86,478 86,478 1,723 0.0004
2021-05-21 2021-03-31 13F/A-1 MIRUM PHARMACEUTICALS COM 604749101 0 -15,437 -100.00 0 -100.00
2021-02-16 2020-12-31 13F MIRUM PHARMACEUTICALS COM 604749101 15,437 -11,442 -42.57 269 -48.07 0.0001
2020-11-16 2020-09-30 13F MIRUM PHARMACEUTICALS COM 604749101 26,879 13,742 104.61 518 102.34 0.0001
2020-08-14 2020-06-30 13F MIRUM PHARMACEUTICALS Cmn 604749101 13,137 13,137 256 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F MIRUM PHARMACEUTICALS COM Call 11,500 -9.45 1,062 5.88 n/a n/a n/a
2026-02-17 2025-12-31 13F MIRUM PHARMACEUTICALS COM Call 12,700 -2.31 1,003 5.25 n/a n/a n/a
2025-11-14 2025-09-30 13F MIRUM PHARMACEUTICALS COM Call 13,000 120.34 953 217.67 n/a n/a n/a
2025-08-14 2025-06-30 13F MIRUM PHARMACEUTICALS COM Call 5,900 -60.14 300 -54.95 n/a n/a n/a
2025-05-15 2025-03-31 13F MIRUM PHARMACEUTICALS COM Call 14,800 469.23 667 522.43 n/a n/a n/a
2025-02-14 2024-12-31 13F MIRUM PHARMACEUTICALS COM Call 2,600 -94.10 108 -93.78 n/a n/a n/a
2024-11-14 2024-09-30 13F MIRUM PHARMACEUTICALS COM Call 44,100 78.54 1,720 103.67 n/a n/a n/a
2024-08-14 2024-06-30 13F MIRUM PHARMACEUTICALS COM Call 24,700 14.35 844 55.72 n/a n/a n/a
2024-05-15 2024-03-31 13F MIRUM PHARMACEUTICALS COM Call 21,600 105.71 543 75.40 n/a n/a n/a
2024-02-14 2023-12-31 13F MIRUM PHARMACEUTICALS COM Call 10,500 45.83 310 36.12 n/a n/a n/a
2023-11-14 2023-09-30 13F MIRUM PHARMACEUTICALS COM Call 7,200 -51.02 228 -40.26 n/a n/a n/a
2023-08-14 2023-06-30 13F MIRUM PHARMACEUTICALS COM Call 14,700 -26.87 380 -21.16 n/a n/a n/a
2023-05-15 2023-03-31 13F MIRUM PHARMACEUTICALS COM Call 20,100 -6.94 483 14.49 n/a n/a n/a
2023-02-14 2022-12-31 13F MIRUM PHARMACEUTICALS COM Call 21,600 22.73 421 13.78 n/a n/a n/a
2022-11-14 2022-09-30 13F MIRUM PHARMACEUTICALS COM Call 17,600 370 n/a n/a n/a
2022-08-15 2022-06-30 13F MIRUM PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2022-05-16 2022-03-31 13F MIRUM PHARMACEUTICALS COM Call 24,900 -26.33 548 1.67 n/a n/a n/a
2022-02-14 2021-12-31 13F MIRUM PHARMACEUTICALS COM Call 33,800 14.19 539 -8.64 n/a n/a n/a
2021-11-15 2021-09-30 13F MIRUM PHARMACEUTICALS Cmn Call 29,600 590 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-17 2025-12-31 13F MIRUM PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-14 2025-09-30 13F MIRUM PHARMACEUTICALS COM Put 20,800 -0.48 1,525 43.37 n/a n/a n/a
2025-08-14 2025-06-30 13F MIRUM PHARMACEUTICALS COM Put 20,900 -22.59 1,064 -12.58 n/a n/a n/a
2025-05-15 2025-03-31 13F MIRUM PHARMACEUTICALS COM Put 27,000 23.29 1,216 34.36 n/a n/a n/a
2025-02-14 2024-12-31 13F MIRUM PHARMACEUTICALS COM Put 21,900 -26.51 906 -22.12 n/a n/a n/a
2024-11-14 2024-09-30 13F MIRUM PHARMACEUTICALS COM Put 29,800 204.08 1,162 246.87 n/a n/a n/a
2024-08-14 2024-06-30 13F MIRUM PHARMACEUTICALS COM Put 9,800 -33.33 335 -9.21 n/a n/a n/a
2024-05-15 2024-03-31 13F MIRUM PHARMACEUTICALS COM Put 14,700 -32.88 369 -42.88 n/a n/a n/a
2024-02-14 2023-12-31 13F MIRUM PHARMACEUTICALS COM Put 21,900 135.48 646 120.48 n/a n/a n/a
2023-11-14 2023-09-30 13F MIRUM PHARMACEUTICALS COM Put 9,300 -14.68 294 4.27 n/a n/a n/a
2023-08-14 2023-06-30 13F MIRUM PHARMACEUTICALS COM Put 10,900 211.43 282 234.52 n/a n/a n/a
2023-05-15 2023-03-31 13F MIRUM PHARMACEUTICALS COM Put 3,500 -50.00 84 -38.24 n/a n/a n/a
2023-02-14 2022-12-31 13F MIRUM PHARMACEUTICALS COM Put 7,000 136 n/a n/a n/a
2022-11-14 2022-09-30 13F MIRUM PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-15 2022-06-30 13F MIRUM PHARMACEUTICALS COM Put 14,600 14.06 284 0.71 n/a n/a n/a
2022-05-16 2022-03-31 13F MIRUM PHARMACEUTICALS COM Put 12,800 -41.28 282 -18.97 n/a n/a n/a
2022-02-14 2021-12-31 13F MIRUM PHARMACEUTICALS COM Put 21,800 -28.29 348 -42.57 n/a n/a n/a
2021-11-15 2021-09-30 13F MIRUM PHARMACEUTICALS Cmn Put 30,400 606 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.